Previous studies on Fyn’s role in cancer, including glioma, show that Fyn is activated via NRAS dependent and independent pathways through the oncogenic receptors EGFR, PDGFR, HGF/MET or RTK/RAS/PI3K to increase cell migration, proliferation and reduce cell death (270–272). The gene discussed is EGFR; the disease is glioma.